---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-25-000063"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T05:01:47.909938+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BeiGene shareholders approve redomestication from Cayman Islands to Switzerland at EGM

## Summary
- Special resolution to deregister in Cayman and continue to Switzerland passed with ~1.035B votes for, ~31K against.
- Related amendment and restatement of articles (Proposed Swiss Articles) approved with similar overwhelming support.
- Ernst & Young AG elected as Swiss statutory auditor until first AGM post-continuation; ~1.029B votes for.
- Continuation remains subject to conditions and is expected to close later this year.
- Quorum of ~74.6% of outstanding shares was present at the Extraordinary General Meeting on April 28, 2025.

## SEC filing metadata
- accession: 0001651308-25-000063
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000063/0001651308-25-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000063/bgne-20250428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-25-000063
- JSON: https://secwatch.observer/filing/0001651308-25-000063.json
- Plain text: https://secwatch.observer/filing/0001651308-25-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.